This opinion letter highlights how digitalisation and automation improve compound synthesis in drug discovery, addressing key bottlenecks in the DMTA cycle.
The Design-Make-Test-Analyse (DMTA) cycle relies on efficient compound synthesis, yet the synthesis ("Make") process remains a significant bottleneck, especially for complex molecules. This opinion letter explores how digitalisation and automation...
No takes yet. Share an insight, caveat, or question.
Nippa et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: